ICP: A novel approach to predict prognosis of prostate cancer with inner-class clustering of gene expression data

被引:5
作者
Kim, Hyunjin [1 ]
Ahn, Jaegyoon [1 ]
Park, Chihyun [1 ]
Yoon, Youngmi [2 ]
Park, Sanghyun [1 ]
机构
[1] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea
[2] Gachon Univ, Dept Comp Engn, Inchon, South Korea
基金
新加坡国家研究基金会;
关键词
Classification; Clustering; Bioinformatics; Microarray data analysis; Prognosis; Prostate cancer; MICROARRAY DATA; CLASSIFICATION; FUSION; SELECTION; MODEL; OVEREXPRESSION; REGRESSION; BIOMARKER; MSMB;
D O I
10.1016/j.compbiomed.2013.06.014
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostate cancer has heterogeneous characteristics. For that reason, even if tumors appear histologically similar to each other, there are many cases in which they are actually different, based on their gene expression levels. A single tumor may have multiple expression levels with both high-risk cancer genes and low-risk cancer genes. We can produce more useful models for stratifying prostate cancers into high-risk cancer and low-risk cancer categories by considering the range in each class through inner-class clustering. In this paper, we attempt to classify cancers into high-risk (aggressive) prostate cancer and low-risk (non-aggressive) prostate cancer using ICP (Inner-class Clustering and Prediction). Our model classified more efficiently than the models of the algorithms used for comparison. After discovering a number of genes linked to prostate cancer from the gene pairs used in our classification, we discovered that the proposed method can be used to find new unknown genes and gene pairs which distinguish between high-risk cancer and low-risk cancer. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1363 / 1373
页数:11
相关论文
共 60 条
[11]   NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate [J].
Bera, TK ;
Das, S ;
Maeda, H ;
Beers, R ;
Wolfgang, CD ;
Kumar, V ;
Hahn, Y ;
Lee, BK ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :3059-3064
[12]  
Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401
[13]  
Bradley P. S., 1998, INFORMS Journal on Computing, V10, P209, DOI 10.1287/ijoc.10.2.209
[14]  
Breiman L., Classification And Regression Trees. eng
[15]   New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy [J].
Cereda, Vittore ;
Poole, Diane J. ;
Palena, Claudia ;
Das, Sudipto ;
Bera, Tapan K. ;
Remondo, Cinzia ;
Gulley, James L. ;
Arlen, Philip M. ;
Yokokawa, Junko ;
Pastan, Ira ;
Schlom, Jeffrey ;
Tsang, Kwong Y. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (01) :63-71
[16]   Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process [J].
Chandran, Uma R. ;
Ma, Changqing ;
Dhir, Rajiv ;
Bisceglia, Michelle ;
Lyons-Weiler, Maureen ;
Liang, Wenjing ;
Michalopoulos, George ;
Becich, Michael ;
Monzon, Federico A. .
BMC CANCER, 2007, 7 (1)
[17]   Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis [J].
Dahlman, Anna ;
Rexhepaj, Elton ;
Brennan, Donal J. ;
Gallagher, William M. ;
Gaber, Alexander ;
Lindgren, Anna ;
Jirstrom, Karin ;
Bjartell, Anders .
MODERN PATHOLOGY, 2011, 24 (05) :708-719
[18]   Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: Prediction and validation [J].
Datta, Moumita ;
Choudhury, Ananyo ;
Lahiri, Ansuman ;
Bhattacharyya, Nitai P. .
BMC GENOMICS, 2011, 12
[19]   Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer [J].
Dong, Zhongyun ;
Liu, Yin ;
Scott, Kieran F. ;
Levin, Linda ;
Gaitonde, Krishnanath ;
Bracken, R. Bruce ;
Burke, Barbara ;
Zhai, Qihui Jim ;
Wang, Jiang ;
Oleksowicz, Leslie ;
Lu, Shan .
CARCINOGENESIS, 2010, 31 (11) :1948-1955
[20]  
Drucker H, 1997, ADV NEUR IN, V9, P155